SIRT2’s established roles in inflammation and glucose and iron metabolism, all known regulators of tumor progression7,12–15, indicate that systemic and microenvironment SIRT2, rather than just expression in tumor cells, might have implications on progression of tumors once they have already undergone tumorigenesis. This evidence concerns the gene SIRT2 and neoplasm.